Examining the Early Distribution of the Artemisinin-Resistant Plasmodium falciparum kelch13 R561H Mutation in Areas of Higher Transmission in Rwanda

Abstract Background Artemisinin resistance mutations in Plasmodium falciparum kelch13 (Pfk13) have begun to emerge in Africa, with Pfk13-R561H being the first reported in Rwanda in 2014, but limited sampling left questions about its early distribution and origin. Methods We genotyped P. falciparum positive dried blood spot (DBS) samples from a nationally representative 2014–2015 Rwanda Demographic Health Surveys (DHS) HIV study. DBS were subsampled from DHS sampling clusters with >15% P. falciparum prevalence, as determined by rapid testing or microscopy done during the DHS study (n clusters = 67, n samples = 1873). Results We detected 476 parasitemias among 1873 residual blood spots from a 2014–2015 Rwanda Demographic Health Survey. We sequenced 351 samples: 341/351 were wild-type (97.03% weighted), and 4 samples (1.34% weighted) harbored R561H that were significantly spatially clustered. Other nonsynonymous mutations found were V555A (3), C532W (1), and G533A (1). Conclusions Our study better defines the early distribution of R561H in Rwanda. Previous studies only observed the mutation in Masaka as of 2014, but our study indicates its presence in higher-transmission regions in the southeast of the country at that time.

[1]  F. Mockenhaupt,et al.  In Vitro Confirmation of Artemisinin Resistance in Plasmodium falciparum from Patient Isolates, Southern Rwanda, 2019 , 2022, Emerging infectious diseases.

[2]  D. Fidock,et al.  Plasmodium falciparum K13 mutations in Africa and Asia impact artemisinin resistance and parasite fitness , 2021, eLife.

[3]  E. Schmitt,et al.  High Prevalence of Plasmodium falciparum K13 Mutations in Rwanda Is Associated With Slow Parasite Clearance After Treatment With Artemether-Lumefantrine , 2021, The Journal of Infectious Diseases.

[4]  Robert M. Waterhouse,et al.  A targeted amplicon sequencing panel to simultaneously identify mosquito species and Plasmodium presence across the entire Anopheles genus , 2021, Molecular ecology resources.

[5]  L. Mutesa,et al.  Association of Plasmodium falciparum kelch13 R561H genotypes with delayed parasite clearance in Rwanda: an open-label, single-arm, multicentre, therapeutic efficacy study. , 2021, The Lancet. Infectious diseases.

[6]  F. Mockenhaupt,et al.  Increase in Kelch 13 Polymorphisms in Plasmodium falciparum, Southern Rwanda , 2021, Emerging infectious diseases.

[7]  Alexander O. B. Whitlock,et al.  Immune selection suppresses the emergence of drug resistance in malaria parasites but facilitates its spread , 2020, bioRxiv.

[8]  J. Bailey,et al.  Changing Prevalence of Potential Mediators of Aminoquinoline, Antifolate, and Artemisinin Resistance Across Uganda. , 2020, The Journal of infectious diseases.

[9]  D. Fidock,et al.  Emergence and clonal expansion of in vitro artemisinin-resistant Plasmodium falciparum kelch13 R561H mutant parasites in Rwanda , 2020, Nature Medicine.

[10]  J. Bailey,et al.  Drug-Resistance and Population Structure of Plasmodium falciparum Across the Democratic Republic of Congo Using High-Throughput Molecular Inversion Probes , 2018, The Journal of infectious diseases.

[11]  J. Bailey,et al.  SeekDeep: single-base resolution de novo clustering for amplicon deep sequencing , 2017, Nucleic acids research.

[12]  F. Mockenhaupt,et al.  Artemisinin Resistance-Associated K13 Polymorphisms of Plasmodium falciparum in Southern Rwanda, 2010-2015. , 2016, The American journal of tropical medicine and hygiene.

[13]  Rwanda Rwanda Demographic and Health Survey 2014-15 , 2016 .

[14]  John C. Tan,et al.  Independent emergence of artemisinin resistance mutations among Plasmodium falciparum in Southeast Asia. , 2015, The Journal of infectious diseases.

[15]  N. Mishra,et al.  Surveillance of Artemisinin Resistance in Plasmodium falciparum in India Using the kelch13 Molecular Marker , 2015, Antimicrobial Agents and Chemotherapy.

[16]  D. Kwiatkowski,et al.  Spread of artemisinin resistance in Plasmodium falciparum malaria. , 2014, The New England journal of medicine.

[17]  B. Genton,et al.  A molecular marker of artemisinin-resistant Plasmodium falciparum malaria , 2013, Nature.

[18]  Nicholas J White,et al.  Antimalarial drug resistance. , 2004, The Journal of clinical investigation.